IP Library Granted Patent US 8,138,218
Granted Patent B2
US 8,138,218 · App. 11/989,181 · Granted Mar 20, 2012

Growth hormone secretagogues

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,138,218
App. No.
11/989,181
Granted
Mar 20, 2012
Kind
B2
Abstract

A family of peptides and peptidomimetic compounds useful as GHS analogs according to either formula (I) or (II) as depicted below: or a pharmaceutically acceptable salts thereof, wherein the variables are as defined in the specification.

Claims (130)

1. A compound of the formula (I)

wherein

X is

Y is H or NR 12 R 13 ;

Z is —C(O)— or —SO 2 —;

n is, independently for each occurrence. 1, 2, 3, 4, 5, 6, 7, or 8;

R 1 and R 3 each is, independently, H or (C 1 -C 4 )alkyl;

R 2 and R 4 each is, independently,

R 5 is H, (C 1 -C 6 )alkyl, (C 2 -C 6 )alkenyl, (C 2 -C 6 )alkynyl, substituted (C 1 -C 6 )alkyl, substituted (C 2 -C 6 )alkenyl, substituted (C 2 -C 6 )alkynyl, aryl, alkylaryl, alkylarylalkyl or arylalkylaryl;

R 8 and R 9 each is, independently, (C 1 -C 6 )alkyl or substituted (C 1 -C 6 )alkyl;

R 6 , R 7 , R 10 , R 11 , R 12 and R 13 each is, independently, H, (C 1 -C 6 )alkyl or substituted (C 1 -C 6 )alkyl; and

Q is H or (C 1 -C 4 )alkyl;

provided that:

at least one of R 2 and R 4 is

 in said compound;

or a pharmaceutically acceptable salt thereof.

2. A compound according to claim 1 , wherein

R 2 is

 and

R 4 is

3. A compound according to claim 2 , wherein Z is —C(O)—.

4. A compound according to claim 3 , wherein

X is

R 6 and R 7 each is, independently, H; and

R 8 and R 9 each is, independently, CH 3 .

5. A compound of claim 4 , wherein

R 1 is H;

R 3 is H or methyl; and

R 5 is H, methyl, ethyl, isopropyl or t-butyl.

6. A compound according to claim 3 , wherein

X is

 and

Y is H.

7. A compound according to claim 6 wherein

R 1 is H;

R 3 is H or methyl; and

R 5 is H, methyl, ethyl, isopropyl or t-butyl.

8. A compound according to claim 3 , wherein

X is

 and

Y is NR 12 R 13 ;

wherein both R 12 and R 13 are each H.

9. A compound of claim 8 wherein

R 1 is H;

R 3 is H or methyl; and

R 5 is H, methyl, ethyl, isopropyl or t-butyl.

10. A compound according to claim 2 , wherein Z is —SO 2 —.

11. A compound according to claim 10 , wherein

X is

R 6 and R 7 each is, independently, H; and

R 8 and R 9 each is, independently, CH 3 .

12. A compound of claim 11 , wherein

R 1 is H;

R 3 is H or methyl; and

R 5 is H, methyl, ethyl, isopropyl or t-butyl.

13. A compound according to claim 10 , wherein

X is

 and

Y is H.

14. A compound according to claim 13 wherein

R 1 is H;

R 3 is H or methyl; and

R 5 is H, methyl, ethyl, isopropyl or t-butyl.

15. A compound according to claim 10 , wherein

X is

 and

Y is NR 12 R 13 ;

wherein both R 12 and R 13 are each H.

16. A compound of claim 15 wherein

R 1 is H;

R 3 is H or methyl; and

R 5 is H, methyl, ethyl, isopropyl or t-butyl.

17. A compound of claim 2 selected from the group consisting of:

or a pharmaceutically acceptable salt thereof.

18. A compound according to claim 1 , wherein

R 2 is

 and

R 4 is

19. A compound of claim 18 selected from the group consisting of:

or a pharmaceutically acceptable salt thereof.

20. A compound according to claim 1 , wherein

R 2 is

 and

R 4 is

21. A compound of claim 20 selected from the group consisting of:

or a pharmaceutically acceptable salt thereof.

22. A compound according to claim 1 , wherein

R 2 is

R 4 is

23. A compound of claim 22 selected from the group consisting of:

or a pharmaceutically acceptable salt thereof.

24. A compound according to claim 1 , wherein

R 2 is

 and

R 4 is

25. A compound according to claim 24 wherein Q is H.

26. A compound of claim 25 selected from the group consisting of:

or a pharmaceutically acceptable salt thereof.

27. A compound according to claim 1 , wherein said compound is according to the formula:

or a pharmaceutically acceptable salt thereof.

28. A pharmaceutical compositions comprising a compound of claim 27 .

29. The composition of claim 28 , in combination with a pharmaceutically acceptable carrier.

30. A compound according to claim 27 , wherein said compound is according to the formula:

or a pharmaceutically acceptable salt thereof.

31. A pharmaceutical compositions comprising a compound of claim 30 .

32. The composition of claim 31 , in combination with a pharmaceutically acceptable carrier.

33. A compound according to claim 30 , wherein said compound is according to the formula:

or a pharmaceutically acceptable salt thereof.

34. A pharmaceutical compositions comprising a compound of claim 33 .

35. The composition of claim 34 , in combination with a pharmaceutically acceptable carrier.

36. A compound according to claim 33 , wherein said compound is according to the formula:

or a pharmaceutically acceptable salt thereof.

37. A pharmaceutical compositions comprising a compound of claim 36 .

38. The composition of claim 37 , in combination with a pharmaceutically acceptable carrier.

39. A compound according to claim 36 , wherein said compound is according to the formula:

or a pharmaceutically acceptable salt thereof.

40. A pharmaceutical compositions comprising a compound of claim 39 .

41. The composition of claim 40 , in combination with a pharmaceutically acceptable carrier.

42. A compound according to claim 39 , wherein said compound is according to the formula:

or a pharmaceutically acceptable salt thereof.

43. A pharmaceutical compositions comprising a compound of claim 42 .

44. The composition of claim 43 , in combination with a pharmaceutically acceptable carrier.

45. A compound according to claim 27 , wherein said compound is according to the formula:

or a pharmaceutically acceptable salt thereof.

46. A pharmaceutical compositions comprising a compound of claim 45 .

47. The composition of claim 46 , in combination with a pharmaceutically acceptable carrier.

48. A compound according to claim 27 , wherein said compound is according to the formula:

or a pharmaceutically acceptable salt thereof.

49. A pharmaceutical compositions comprising a compound of claim 48 .

50. The composition of claim 49 , in combination with a pharmaceutically acceptable carrier.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNOR NAME PREVIOUSLY RECORDED ON REEL 296336 FRAME 0777. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jan 5, 2016
From: SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES, S.A.S.
To: IPSEN PHARMA S.A.S.
Reel/Frame 037430/0194 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ADDRESS PREVIOUSLY RECORDED ON REEL 023034 FRAME 0251. ASSIGNOR(S) HEREBY CONFIRMS THE ADDRESS SHOULD BE 65 QUAI GEORGES GORSE, 92100 BOULOGNE-BILLANCOURT, FRANCE. Recorded Jan 16, 2013
From: SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATION SCIENTIFIQUES (S.C.R.A.S.)
To: IPSEN PHARMA S.A.S.
Reel/Frame 029636/0777 →
CHANGE OF NAME Recorded Jul 31, 2009
From: SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATION SCIENTIFIQUES (S.C.R.A.S.)
To: IPSEN PHARMA S.A.S.
Reel/Frame 023034/0251 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 17, 2008
From: DONG, ZHENG XIN; SHEN, YEELANA; EYNON, JOHN
To: BIOMEASURE, INCORPORATED
Reel/Frame 020816/0877 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 17, 2008
From: BIOMEASURE, INCORPORATED
To: SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES, S.A.S.
Reel/Frame 020816/0882 →